Clinical Trials for Apocrine Gland Anal Sac Adenocarcinoma
Apocrine gland anal sac adenocarcinoma (AGASACA) is a malignant tumor arising from the apocrine glands of the anal sacs, most commonly affecting dogs and occasionally cats. It frequently spreads to regional lymph nodes and can cause hypercalcemia. University clinical trials are actively researching new treatment combinations including surgery, radiation, and systemic therapies that may be fully or partially funded.
12 active trials currently enrolling
Trials available at institutions in:
Understanding Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) in Pets
This cancer arises from the glands of the anal sacs and is most commonly seen in dogs, though it occasionally affects cats. It frequently spreads to nearby lymph nodes and can cause elevated calcium levels.
Who it tends to affect
- Typical size: Affects both dogs and cats; no consistent size predisposition has been established in dogs
- Typical age: Most commonly diagnosed in middle-aged to older dogs, typically 8 years and older
Can my pet join — does breed matter?
Trials typically enroll based on lymph node involvement, calcium status, and prior treatment. Both dogs and cats meeting diagnostic and health criteria may be eligible.
Most trials are open to all breeds and set requirements by size, weight, age, and diagnosis instead. Our matching service checks your pet's specific details against each study's actual requirements.
Where Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Trials Are Running
Active research locations are spread across the country. Current coverage by region:
States with active sites include: MO, WI, CO, KS, AL. We expand the search to nearby states when there's no local match.
What Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Trials Typically Cost
Many trials cover part or all of treatment costs. Of the 12 trials we're currently tracking for apocrine gland anal sac adenocarcinoma (agasaca):
The trials themselves are run by research institutions — we don't charge for them. Funding status changes as studies open and close, so we confirm current coverage when we match your pet.
What Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Research Is Focused On
Current studies for apocrine gland anal sac adenocarcinoma (agasaca) are exploring approaches like:
- •Combination surgery and radiation
- •Systemic chemotherapy protocols
- •Hypercalcemia management strategies
- •Targeted therapy approaches
How it works
Tell us about your pet
Share the diagnosis, your pet's age and size, and your location. It takes a few minutes — no account needed.
We research current trials
We check open studies against your pet's actual eligibility — diagnosis, stage, location, and prior treatment. Most matches come back in 2–3 days.
You get your matches
A personalized list of trials your pet may qualify for, with locations, funding status, and exactly how to enroll.
The trials themselves are free and run by research institutions. Our fee covers the research and eligibility matching — and if we don't find any matches for your pet, you don't pay.
Find trials for my pet with Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) now
Our matching service screens all 12 active Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) trials against your pet’s specific profile — age, breed, stage, and location.
$7 to see your matches · $23 only if trials are found
Check My Pet’s Eligibility Now →Find Trials for Your Pet
Our free matching service screens 147 active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet